A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus

NCT01029795 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

38

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to nonclinical safety findings

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2599506
DRUG: Glyburide
DRUG: Placebo

Sponsor

Eli Lilly and Company